The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bio Similars & Subsequent Entry Biologic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio Similars & Subsequent Entry Biologic Market Perspective (2019-2030)
2.2 Bio Similars & Subsequent Entry Biologic Growth Trends by Region
2.2.1 Global Bio Similars & Subsequent Entry Biologic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio Similars & Subsequent Entry Biologic Historic Market Size by Region (2019-2024)
2.2.3 Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Region (2025-2030)
2.3 Bio Similars & Subsequent Entry Biologic Market Dynamics
2.3.1 Bio Similars & Subsequent Entry Biologic Industry Trends
2.3.2 Bio Similars & Subsequent Entry Biologic Market Drivers
2.3.3 Bio Similars & Subsequent Entry Biologic Market Challenges
2.3.4 Bio Similars & Subsequent Entry Biologic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio Similars & Subsequent Entry Biologic Players by Revenue
3.1.1 Global Top Bio Similars & Subsequent Entry Biologic Players by Revenue (2019-2024)
3.1.2 Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Players (2019-2024)
3.2 Global Bio Similars & Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bio Similars & Subsequent Entry Biologic Revenue
3.4 Global Bio Similars & Subsequent Entry Biologic Market Concentration Ratio
3.4.1 Global Bio Similars & Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Similars & Subsequent Entry Biologic Revenue in 2023
3.5 Bio Similars & Subsequent Entry Biologic Key Players Head office and Area Served
3.6 Key Players Bio Similars & Subsequent Entry Biologic Product Solution and Service
3.7 Date of Enter into Bio Similars & Subsequent Entry Biologic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Similars & Subsequent Entry Biologic Breakdown Data by Type
4.1 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Type (2019-2024)
4.2 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Type (2025-2030)
5 Bio Similars & Subsequent Entry Biologic Breakdown Data by Application
5.1 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Application (2019-2024)
5.2 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bio Similars & Subsequent Entry Biologic Market Size (2019-2030)
6.2 North America Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024)
6.4 North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio Similars & Subsequent Entry Biologic Market Size (2019-2030)
7.2 Europe Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024)
7.4 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size (2019-2030)
8.2 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2019-2024)
8.4 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio Similars & Subsequent Entry Biologic Market Size (2019-2030)
9.2 Latin America Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024)
9.4 Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size (2019-2030)
10.2 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024)
10.4 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sun Pharma
11.1.1 Sun Pharma Company Detail
11.1.2 Sun Pharma Business Overview
11.1.3 Sun Pharma Bio Similars & Subsequent Entry Biologic Introduction
11.1.4 Sun Pharma Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.1.5 Sun Pharma Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Detail
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Detail
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Detail
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Bio Similars & Subsequent Entry Biologic Introduction
11.4.4 LG Life Sciences Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Detail
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Introduction
11.5.4 Celltrion Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Detail
11.6.2 Hospira Business Overview
11.6.3 Hospira Bio Similars & Subsequent Entry Biologic Introduction
11.6.4 Hospira Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.6.5 Hospira Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Bio Similars & Subsequent Entry Biologic Introduction
11.7.4 Merck Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Detail
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Bio Similars & Subsequent Entry Biologic Introduction
11.8.4 Biogen idec Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Detail
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Introduction
11.9.4 Genentech (Roche) Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Bio Similars & Subsequent Entry Biologic Introduction
11.10.4 Pfizer Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.10.5 Pfizer Recent Development
11.11 Celltrion
11.11.1 Celltrion Company Detail
11.11.2 Celltrion Business Overview
11.11.3 Celltrion Bio Similars & Subsequent Entry Biologic Introduction
11.11.4 Celltrion Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.11.5 Celltrion Recent Development
11.12 Biocon
11.12.1 Biocon Company Detail
11.12.2 Biocon Business Overview
11.12.3 Biocon Bio Similars & Subsequent Entry Biologic Introduction
11.12.4 Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.12.5 Biocon Recent Development
11.13 Amgen
11.13.1 Amgen Company Detail
11.13.2 Amgen Business Overview
11.13.3 Amgen Bio Similars & Subsequent Entry Biologic Introduction
11.13.4 Amgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.13.5 Amgen Recent Development
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Detail
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Bio Similars & Subsequent Entry Biologic Introduction
11.14.4 Samsung Biologics Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.14.5 Samsung Biologics Recent Development
11.15 Mylan
11.15.1 Mylan Company Detail
11.15.2 Mylan Business Overview
11.15.3 Mylan Bio Similars & Subsequent Entry Biologic Introduction
11.15.4 Mylan Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.15.5 Mylan Recent Development
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Detail
11.16.2 Dr. Reddy's Laboratories Business Overview
11.16.3 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Introduction
11.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.16.5 Dr. Reddy's Laboratories Recent Development
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Detail
11.17.2 Stada Arzneimittel AG Business Overview
11.17.3 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Introduction
11.17.4 Stada Arzneimittel AG Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.17.5 Stada Arzneimittel AG Recent Development
11.18 AbbVie
11.18.1 AbbVie Company Detail
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Bio Similars & Subsequent Entry Biologic Introduction
11.18.4 AbbVie Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.18.5 AbbVie Recent Development
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Detail
11.19.2 Sanofi-Aventis Business Overview
11.19.3 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Introduction
11.19.4 Sanofi-Aventis Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.19.5 Sanofi-Aventis Recent Development
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Detail
11.20.2 Johnson & Johnson Business Overview
11.20.3 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Introduction
11.20.4 Johnson & Johnson Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.20.5 Johnson & Johnson Recent Development
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Detail
11.21.2 Novo Nordisk Business Overview
11.21.3 Novo Nordisk Bio Similars & Subsequent Entry Biologic Introduction
11.21.4 Novo Nordisk Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.21.5 Novo Nordisk Recent Development
11.22 Eli Lilly
11.22.1 Eli Lilly Company Detail
11.22.2 Eli Lilly Business Overview
11.22.3 Eli Lilly Bio Similars & Subsequent Entry Biologic Introduction
11.22.4 Eli Lilly Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.22.5 Eli Lilly Recent Development
11.23 Novartis
11.23.1 Novartis Company Detail
11.23.2 Novartis Business Overview
11.23.3 Novartis Bio Similars & Subsequent Entry Biologic Introduction
11.23.4 Novartis Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.23.5 Novartis Recent Development
11.24 3sbio
11.24.1 3sbio Company Detail
11.24.2 3sbio Business Overview
11.24.3 3sbio Bio Similars & Subsequent Entry Biologic Introduction
11.24.4 3sbio Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.24.5 3sbio Recent Development
11.25 Biotech
11.25.1 Biotech Company Detail
11.25.2 Biotech Business Overview
11.25.3 Biotech Bio Similars & Subsequent Entry Biologic Introduction
11.25.4 Biotech Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.25.5 Biotech Recent Development
11.26 Gelgen
11.26.1 Gelgen Company Detail
11.26.2 Gelgen Business Overview
11.26.3 Gelgen Bio Similars & Subsequent Entry Biologic Introduction
11.26.4 Gelgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.26.5 Gelgen Recent Development
11.27 Innovent
11.27.1 Innovent Company Detail
11.27.2 Innovent Business Overview
11.27.3 Innovent Bio Similars & Subsequent Entry Biologic Introduction
11.27.4 Innovent Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.27.5 Innovent Recent Development
11.28 Dong Bao
11.28.1 Dong Bao Company Detail
11.28.2 Dong Bao Business Overview
11.28.3 Dong Bao Bio Similars & Subsequent Entry Biologic Introduction
11.28.4 Dong Bao Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.28.5 Dong Bao Recent Development
11.29 Ganlee
11.29.1 Ganlee Company Detail
11.29.2 Ganlee Business Overview
11.29.3 Ganlee Bio Similars & Subsequent Entry Biologic Introduction
11.29.4 Ganlee Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
11.29.5 Ganlee Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Vaccines
Table 7. Key Players of Others
Table 8. Global Bio Similars & Subsequent Entry Biologic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Bio Similars & Subsequent Entry Biologic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Bio Similars & Subsequent Entry Biologic Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Bio Similars & Subsequent Entry Biologic Market Share by Region (2019-2024)
Table 12. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Bio Similars & Subsequent Entry Biologic Market Share by Region (2025-2030)
Table 14. Bio Similars & Subsequent Entry Biologic Market Trends
Table 15. Bio Similars & Subsequent Entry Biologic Market Drivers
Table 16. Bio Similars & Subsequent Entry Biologic Market Challenges
Table 17. Bio Similars & Subsequent Entry Biologic Market Restraints
Table 18. Global Bio Similars & Subsequent Entry Biologic Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Bio Similars & Subsequent Entry Biologic Market Share by Players (2019-2024)
Table 20. Global Top Bio Similars & Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars & Subsequent Entry Biologic as of 2023)
Table 21. Ranking of Global Top Bio Similars & Subsequent Entry Biologic Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Bio Similars & Subsequent Entry Biologic Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Bio Similars & Subsequent Entry Biologic Product Solution and Service
Table 25. Date of Enter into Bio Similars & Subsequent Entry Biologic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bio Similars & Subsequent Entry Biologic Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Type (2019-2024)
Table 29. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Type (2025-2030)
Table 31. Global Bio Similars & Subsequent Entry Biologic Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Application (2019-2024)
Table 33. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Application (2025-2030)
Table 35. North America Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2025-2030) & (US$ Million)
Table 50. Sun Pharma Company Detail
Table 51. Sun Pharma Business Overview
Table 52. Sun Pharma Bio Similars & Subsequent Entry Biologic Product
Table 53. Sun Pharma Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 54. Sun Pharma Recent Development
Table 55. Synthon Pharmaceuticals Company Detail
Table 56. Synthon Pharmaceuticals Business Overview
Table 57. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product
Table 58. Synthon Pharmaceuticals Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 59. Synthon Pharmaceuticals Recent Development
Table 60. Teva Pharmaceutical Industries Company Detail
Table 61. Teva Pharmaceutical Industries Business Overview
Table 62. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product
Table 63. Teva Pharmaceutical Industries Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 64. Teva Pharmaceutical Industries Recent Development
Table 65. LG Life Sciences Company Detail
Table 66. LG Life Sciences Business Overview
Table 67. LG Life Sciences Bio Similars & Subsequent Entry Biologic Product
Table 68. LG Life Sciences Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 69. LG Life Sciences Recent Development
Table 70. Celltrion Biocon Company Detail
Table 71. Celltrion Biocon Business Overview
Table 72. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product
Table 73. Celltrion Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 74. Celltrion Biocon Recent Development
Table 75. Hospira Company Detail
Table 76. Hospira Business Overview
Table 77. Hospira Bio Similars & Subsequent Entry Biologic Product
Table 78. Hospira Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 79. Hospira Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Bio Similars & Subsequent Entry Biologic Product
Table 83. Merck Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Biogen idec Company Detail
Table 86. Biogen idec Business Overview
Table 87. Biogen idec Bio Similars & Subsequent Entry Biologic Product
Table 88. Biogen idec Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 89. Biogen idec Recent Development
Table 90. Genentech (Roche) Company Detail
Table 91. Genentech (Roche) Business Overview
Table 92. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product
Table 93. Genentech (Roche) Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 94. Genentech (Roche) Recent Development
Table 95. Pfizer Company Detail
Table 96. Pfizer Business Overview
Table 97. Pfizer Bio Similars & Subsequent Entry Biologic Product
Table 98. Pfizer Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Celltrion Company Detail
Table 101. Celltrion Business Overview
Table 102. Celltrion Bio Similars & Subsequent Entry Biologic Product
Table 103. Celltrion Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 104. Celltrion Recent Development
Table 105. Biocon Company Detail
Table 106. Biocon Business Overview
Table 107. Biocon Bio Similars & Subsequent Entry Biologic Product
Table 108. Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 109. Biocon Recent Development
Table 110. Amgen Company Detail
Table 111. Amgen Business Overview
Table 112. Amgen Bio Similars & Subsequent Entry Biologic Product
Table 113. Amgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 114. Amgen Recent Development
Table 115. Samsung Biologics Company Detail
Table 116. Samsung Biologics Business Overview
Table 117. Samsung Biologics Bio Similars & Subsequent Entry Biologic Product
Table 118. Samsung Biologics Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 119. Samsung Biologics Recent Development
Table 120. Mylan Company Detail
Table 121. Mylan Business Overview
Table 122. Mylan Bio Similars & Subsequent Entry Biologic Product
Table 123. Mylan Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 124. Mylan Recent Development
Table 125. Dr. Reddy's Laboratories Company Detail
Table 126. Dr. Reddy's Laboratories Business Overview
Table 127. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product
Table 128. Dr. Reddy's Laboratories Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 129. Dr. Reddy's Laboratories Recent Development
Table 130. Stada Arzneimittel AG Company Detail
Table 131. Stada Arzneimittel AG Business Overview
Table 132. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product
Table 133. Stada Arzneimittel AG Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 134. Stada Arzneimittel AG Recent Development
Table 135. AbbVie Company Detail
Table 136. AbbVie Business Overview
Table 137. AbbVie Bio Similars & Subsequent Entry Biologic Product
Table 138. AbbVie Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 139. AbbVie Recent Development
Table 140. Sanofi-Aventis Company Detail
Table 141. Sanofi-Aventis Business Overview
Table 142. Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Product
Table 143. Sanofi-Aventis Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 144. Sanofi-Aventis Recent Development
Table 145. Johnson & Johnson Company Detail
Table 146. Johnson & Johnson Business Overview
Table 147. Johnson & Johnson Bio Similars & Subsequent Entry Biologic Product
Table 148. Johnson & Johnson Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 149. Johnson & Johnson Recent Development
Table 150. Novo Nordisk Company Detail
Table 151. Novo Nordisk Business Overview
Table 152. Novo Nordisk Bio Similars & Subsequent Entry Biologic Product
Table 153. Novo Nordisk Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 154. Novo Nordisk Recent Development
Table 155. Eli Lilly Company Detail
Table 156. Eli Lilly Business Overview
Table 157. Eli Lilly Bio Similars & Subsequent Entry Biologic Product
Table 158. Eli Lilly Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 159. Eli Lilly Recent Development
Table 160. Novartis Company Detail
Table 161. Novartis Business Overview
Table 162. Novartis Bio Similars & Subsequent Entry Biologic Product
Table 163. Novartis Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 164. Novartis Recent Development
Table 165. 3sbio Company Detail
Table 166. 3sbio Business Overview
Table 167. 3sbio Bio Similars & Subsequent Entry Biologic Product
Table 168. 3sbio Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 169. 3sbio Recent Development
Table 170. Biotech Company Detail
Table 171. Biotech Business Overview
Table 172. Biotech Bio Similars & Subsequent Entry Biologic Product
Table 173. Biotech Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 174. Biotech Recent Development
Table 175. Gelgen Company Detail
Table 176. Gelgen Business Overview
Table 177. Gelgen Bio Similars & Subsequent Entry Biologic Product
Table 178. Gelgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 179. Gelgen Recent Development
Table 180. Innovent Company Detail
Table 181. Innovent Business Overview
Table 182. Innovent Bio Similars & Subsequent Entry Biologic Product
Table 183. Innovent Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 184. Innovent Recent Development
Table 185. Dong Bao Company Detail
Table 186. Dong Bao Business Overview
Table 187. Dong Bao Bio Similars & Subsequent Entry Biologic Product
Table 188. Dong Bao Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 189. Dong Bao Recent Development
Table 190. Ganlee Company Detail
Table 191. Ganlee Business Overview
Table 192. Ganlee Bio Similars & Subsequent Entry Biologic Product
Table 193. Ganlee Revenue in Bio Similars & Subsequent Entry Biologic Business (2019-2024) & (US$ Million)
Table 194. Ganlee Recent Development
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bio Similars & Subsequent Entry Biologic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Bio Similars & Subsequent Entry Biologic Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Interferon Features
Figure 5. Erythropoietin Features
Figure 6. Insulin Features
Figure 7. Vaccines Features
Figure 8. Others Features
Figure 9. Global Bio Similars & Subsequent Entry Biologic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Bio Similars & Subsequent Entry Biologic Market Share by Application: 2023 VS 2030
Figure 11. Tumor Case Studies
Figure 12. Diabetes Case Studies
Figure 13. Cardiovascular Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Others Case Studies
Figure 16. Bio Similars & Subsequent Entry Biologic Report Years Considered
Figure 17. Global Bio Similars & Subsequent Entry Biologic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Bio Similars & Subsequent Entry Biologic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Bio Similars & Subsequent Entry Biologic Market Share by Region: 2023 VS 2030
Figure 20. Global Bio Similars & Subsequent Entry Biologic Market Share by Players in 2023
Figure 21. Global Top Bio Similars & Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars & Subsequent Entry Biologic as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Bio Similars & Subsequent Entry Biologic Revenue in 2023
Figure 23. North America Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Bio Similars & Subsequent Entry Biologic Market Share by Country (2019-2030)
Figure 25. United States Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Bio Similars & Subsequent Entry Biologic Market Share by Country (2019-2030)
Figure 29. Germany Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Share by Region (2019-2030)
Figure 37. China Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Bio Similars & Subsequent Entry Biologic Market Share by Country (2019-2030)
Figure 45. Mexico Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Share by Country (2019-2030)
Figure 49. Turkey Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Sun Pharma Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 52. Synthon Pharmaceuticals Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 53. Teva Pharmaceutical Industries Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 54. LG Life Sciences Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 55. Celltrion Biocon Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 56. Hospira Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 57. Merck Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 58. Biogen idec Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 59. Genentech (Roche) Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 60. Pfizer Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 61. Celltrion Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 62. Biocon Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 63. Amgen Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 64. Samsung Biologics Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 65. Mylan Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 66. Dr. Reddy's Laboratories Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 67. Stada Arzneimittel AG Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 68. AbbVie Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 69. Sanofi-Aventis Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 70. Johnson & Johnson Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 71. Novo Nordisk Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 72. Eli Lilly Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 73. Novartis Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 74. 3sbio Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 75. Biotech Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 76. Gelgen Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 77. Innovent Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 78. Dong Bao Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 79. Ganlee Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2019-2024)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed